Home LiteratureArticle Details
PMID: 16681596 Published · ppublish English

Analysis of gene mutations in four cases of dermatofibrosarcoma protuberans.

Clinical and experimental dermatology ·Vol. 31 ·No. 3 ·2006-09-14

Saeki H, Tamada Y, Watanabe D, Akita Y, Matsumoto Y, Imai C, Kadono T, Maekawa T, Hattori N, Watanabe A, Torii H, Tamaki K

Abstract

Fusion of the collagen type I alpha 1 (COL1A1) gene with the platelet-derived growth factor B-chain (PDGFB) gene has been described in dermatofibrosarcoma protuberans (DFSP). Various exons of the COL1A1 gene have been shown to be involved in the fusion with exon 2 of the PDGFB gene. We examined the breakpoints of the COL1A1 gene using the tumour specimens from four patients with DFSP. The COL1A1-PDGFB fusion transcripts were detected from the cultured tumour cells by reverse transcriptase polymerase chain reaction. Sequence analysis revealed that the ends of exons 23, 25, 26 and 36 in the COL1A1 gene were fused with the start of exon 2 in the PDGFB. This study identified three novel COL1A1 breakpoints: exons 23, 26 and 36 of the COL1A1 gene. In one case, the tumour was composed of two areas that differed in cytological atypia, cellularity and mitotic activity, indicating the dedifferentiation of the tumour. In tumour cells from two different areas the same aberrant fusion transcripts were identified. These results suggest that the dedifferentiation of tumour cells has nothing to do with the specific breakpoints of the COL1A1 gene, but depends on other unknown factors.

Article Info
Journal
Clinical and experimental dermatology
Abbr.
Clin Exp Dermatol
Published
2006-09-14
Indexed
2006-05-09
Updated
2006-05-09
Language
English
Country/Region
England
NLM ID
7606847
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]